Major Depressive Disorder Clinical Trial
Official title:
Jump Step - A Participatory Approach to Physical Activity & Mental Wellness
The WHO, the Pan American Health Organization, the EU Council of Ministers, the World
Federation of Mental Health, and the UK Royal College of Psychiatrists all agree -"there can
be no health without mental health". Within Canada, 6.7M people live with a mental illness
and when family and caregivers are included almost everyone is affected.
A systematic review (2014) concluded that physical activity has a significant potential for
reducing depressive symptoms in people with a mental illness. Globally, physical inactivity
is "pandemic". Current guidelines recommend a minimum of only a 150 minutes a week of
moderately vigorous exercise but 85% of Canadians do not meet the national recommendations.
How then can people with depression be motivated to become physically more active?
Group Medical Visits (GMVs) can be used to provide health services and they have proven
effective in some settings, including mood disorders. As well as providing economic and
resource efficiencies, the GMV model has the potential to add a 'support
group/accountability' element for behavioural interventions such as physical activity
promotion; such influence is not present in an individual patient-physician consultation.
"Jump Step" is a 14-week program within a GMV setting designed to motivate and support
people with depression to engage in regular physical activity. The investigators seek to
design, implement, and evaluate the effectiveness of the Group Medical Visits focused on
promoting physical activity for patients with depression.
Mental disorders, including anxiety and depression, contribute more than either
cardiovascular disease or cancer to the burden of disease worldwide. Individuals with
chronic diseases and major depression use more health resources, have higher degrees of
functional disability, and experience higher productivity losses, compared to their
counterparts without major depression. Within Canada, 6.7M people live with a mental illness
and when family and caregivers are included almost everyone is affected.
A Cochrane Review examined the effectiveness of exercise in treating depression and the
results of 39 trials and over 2,300 subjects confirmed a moderate effect for exercise when
compared to no treatment or a control group. A smaller number of studies found no
differences in efficacy between exercise and Cognitive Behavioural Therapy (CBT) and/or
antidepressant therapies, the current "gold standards" for depression care. A systematic
review (2014) concluded that physical activity has a significant potential for reducing
depressive symptoms in people with a mental health challenge.
Globally, physical inactivity is "pandemic". Current guidelines recommend a minimum of only
150 minutes a week of moderately vigorous exercise but 85% of Canadians do not meet the
national recommendations. There is no question that physical activity can be an effective
treatment; how then can people dealing with depression be motivated to become physically
more active?
The majority of psychiatric care for mood disorders is delivered through one-to-one
consultations between a patient and psychiatrist or family physician. Treatment plans rarely
include physical activity despite evidence for its effectiveness. In fact, efforts to
promote physical activity within traditional clinical settings are fraught with challenges
such as a lack of practitioner resources, reimbursement, time, and confidence, and poor
patient retention. Instead, people are commonly prescribed powerful pharmaceuticals despite
mounting evidence that these drugs should be reserved for the most serious cases of anxiety
and depression. While drugs have their place, this place is firmly behind interventions such
as psychotherapy and physical activity in the majority of cases of depression.
Novel strategies are needed for promoting physical activity and self-management that are
also physically, financially, and psychologically accessible. Group Medical Visits (GMVs)
are a promising approach to mental health care. Group Medical Visits are organized around a
group of people living with a specific condition. The structure and formats of GMVs vary.
Typically, in lieu of a short individual visit, a patient will participate in a longer
(60-120 minutes) group visit with six to 14 other patients, led by a physician and/or other
healthcare practitioner.
GMVs have been scientifically tested in an array of primary care settings over the last 10
to 15 years, including mental health[6-8]; no studies to date, though, have focused
exclusively on physical activity promotion. Briefly, the theoretical rationale for this
approach is a multifactorial "interdisciplinary model", including medication/treatment
monitoring, patient education, social support, goal setting, and motivation for improving
person's self-perception to uptake physical activity.
Within British Columbia, the Mood Disorders Association of BC has taken a leadership role in
integrating Group Medical Visits into psychiatric care. Based on the success of MDABC's
adult Group Medical Visits, UBC researchers collaborated with MDABC to design and prototype
"Step-by-Step (SBS)." SBS was a series of 14 weekly Group Appointments designed to help
patients with anxiety and/or depression incorporate physical activity as part of their
treatment plan.
Co-led by a psychiatrist and an exercise therapist, each two-hour GMV combined specific
participants' self-management and activation. A physical activity section in each Group
Appointment provided participants instruction in techniques/exercises that they could employ
in their everyday lives to become more physically active without having to attend special
classes, set aside time, or make concerted efforts to "exercise".
After three months post-SBS intervention, median depression scales (PHQ-9) decreased 38%
from 16 to 10 (p<0.01; IQR: 8/12); and, median anxiety scales (GAD-7) decreased 50% from 13
to 6.5 (p<0.05; IQR: 8.5/9). Median daily "steps" increased 71% from 3,366 to 5,746 (IQR:
2,610/6,237), though this was not significant (p>0.10). These data compare favourably with
other interventions such as psychotherapy and medications. Fourteen of 15 participants
(93.3%) completed the 14-week program and loved it!
In the design and realization of Step-by-Step the investigators intentionally 'meet
participants where they were at." The intervention was not static but a dynamic constantly
evolving process whereby the investigators continuously refined the program based on weekly
feedback. As a result, the investigators were able to better able to meet the needs of
participants though it did mean what the investigators were testing changed over the course
of the intervention.
Equally, the investigators intended the program to address participants holistically, which
therefore demanded a multifactorial approach. Instead of testing a single variable the
investigators were examining the impact of a collection of elements as a whole. Exit
interviews with participants suggested a number of factors might have led to program
retention and the improvements in physical activity, depression, and anxiety. The
investigators cannot say definitely which components of the program had impact, only that as
a whole the investigators did see improvements.
In light of the above evidence regarding physical activity's impact on well being, one could
reasonably offer that as a society we have a moral and ethical obligation to promote
physical activity as a first-line treatment for depression. The question remains 'how can
individuals, dealing with depression, be better motivated to become more physically active?'
The promotion of physical activity through GMVs and the inclusion of a physical activity
component within group patient visits are worthy of further investigation.
STUDY PROPOSAL: Through a mixed methods approach the investigators will evaluate the success
of Jump Step, a series of 14 Group Medical Visits in motivating adults (≥18yrs), dealing
with depression to become more physically active.
HYPOTHESIS: The investigators propose that adults dealing with Major Depressive Disorder
(MDD) and/or Bi Polar II, depression, who participate in a weekly series of 14 Group Medical
Visits (Jump Step) will have lower depression and anxiety ratings, higher rates of physical
activity/step counts, and higher levels of "patient activation" post-intervention as
compared to pre-intervention. Participants will also report deeper engagement and confidence
in physical activity; increased levels of self-care and treatment as well as greater well
being in qualitative interviews.
The investigators will recruit volunteers via the following approaches:
1. Posters located in A) the Mood Disorders Association of BC (MDABC); B) the psychiatric
services area of major hospitals; C) areas visible to potential volunteers within
related services organizations; D) coffee shops, community centres, YMCAs, and such
venues. The investigators will obtain permission from the appropriate authorities to
display advertisements;
2. Postings on the websites/list-serves of related service organizations such as the
MDABC, the BC Psychiatric Association, BC Mental Health & Addiction Services, and
Health Authority Mental Health Services. The investigators will obtain permission from
the appropriate authorities to display advertisements;
3. Through word-of-mouth at MDABC and other service agencies and any resulting 'snowball
sampling'.
4. Through social media such as Facebook and Twitter.
5. If needed the investigators will advertise in Lower Mainland papers.
MDABC psychiatrists and staff will also verbally inform clients of the opportunity to
participate with the understanding that participation or non-participation will not affect a
client's access to or quality of psychiatric care and/or MDABC services.
Previous participants in the Jump Step Needs Assessment (Part 1) (UBC Ethics: H14-00973) who
meet the eligibility criteria and have signed consent will be given first preference.
Volunteers will either be emailed a blank consent form and a Physical Activity Readiness
Questionnaire (2014 PAR-Q+) or obtain them through the MDABC office. Potential participants
will scan and email their signed consent form and the PARQ+ form and Participant Declaration
back to the Research Assistant; or they will mail signed paper copies of the forms back to
the office of the investigators at the CHHM. Self Addressed Stamped Envelopes (SASEs) will
be available at the MDABC office for this purposed. If needed the investigators will mail
consent forms to potential participant along with a SASE.
Participants will have up to one-week prior to the baseline assessment or a minimum of 48
hours to review the consent form, ask questions, and/or discuss the consent with family
members, friends, etc. The investigators believe 48 hours provides sufficient time for
reflection and/or conversation and provides their Research Assistant with sufficient time to
adequate schedule interviews.
Potential participants will contact their Research Assistant who will answer questions,
confirm their eligibility, and schedule them for interviews. Each potential participant will
have filled out, signed, and submitted the Physical Activity Readiness Questionnaire (2014
PAR-Q+). Research staff and/or the psychiatrist will follow up as appropriate, regarding
their responses in the PARQ+.
Each assessment (baseline/post-intervention) will take approximately 90 minutes. The
investigators will reimburse each participant $5 for each assessment they attend as well
their parking/public transit up to $5.50 per assessment.
Professional transcription services will transcribe the interviews. Jump Step investigators
will then analyze the data for common themes.
Intervention participants who have signed consent will be divided into cohorts of 20
participants each. Cohorts will participate in a weekly series of 14 Group Medical Visits
(GMVs) co-led by a MDABC psychiatrist and an exercise therapist. GMVs will take place at the
centrally located Robert Lee YMCA (downtown Vancouver), which will provide access to both
meeting space for the group discussions as well as exercise facilities for the physical
activity component of each Visit.
The curriculum will include (i) life skills development; (ii) disease specific education,
relating to physical activity promotion, uptake, and adherence. The investigators will
present also this education within a broader holistic context that acknowledges and supports
a participant's social, emotional, spiritual, financial, physical, and nutritional well
being; and (iii) GMVs will integrate medical care/medication management into their delivery.
During the physical activity component, participants will take part in regular group walks,
emphasizing that 150 minutes weekly of moderate activity (e.g. brisk walking) is all that is
necessary to obtain the medical benefits offered by regular physical activity. On other
weeks participants will stay in the YMCA and be taught techniques and exercises that they
can employ in their everyday lives to become more physically active without having to attend
special classes, set aside time, or make concerted efforts to "exercise".
Group exercises might include aerobic training of cardio respiratory functioning, circuit
training with simple tasks, e.g. ergometer bicycling, resistance bands, light weightlifting,
etc. A trainer will supervise all interventions. Each subject will be given a physical
activity sensor (Fit Bit) and participants will receive instruction from a researcher as to
logging the wear time daily.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05537558 -
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
|
||
Terminated |
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 | |
Completed |
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 | |
Recruiting |
NCT05547035 -
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
|
N/A | |
Terminated |
NCT02940769 -
Neurobiological Effects of Light on MDD
|
N/A | |
Recruiting |
NCT05892744 -
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
|
Phase 4 | |
Recruiting |
NCT05537584 -
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
|
Phase 4 | |
Active, not recruiting |
NCT05061706 -
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
|
Phase 3 | |
Completed |
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 | |
Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
Recruiting |
NCT05527951 -
Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study
|
N/A | |
Completed |
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 | |
Recruiting |
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A | |
Recruiting |
NCT05895747 -
5-HTP and Creatine for Depression R33 Phase
|
Phase 2 | |
Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
Recruiting |
NCT05813093 -
Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
|
N/A | |
Recruiting |
NCT05135897 -
The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
|
||
Enrolling by invitation |
NCT04509102 -
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
|
Early Phase 1 | |
Recruiting |
NCT06145594 -
EMA-Guided Maintenance TMS for Depression
|
N/A | |
Recruiting |
NCT06026917 -
Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
|
Phase 4 |